Fate Therapeutics, Inc.
US ˙ NasdaqGM ˙ US31189P1021

SecurityFATE / Fate Therapeutics, Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership0 shares
Ownership 0.00%
Vanguard Group Inc ownership in FATE / Fate Therapeutics, Inc.

2026-03-26 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Fate Therapeutics, Inc. (US:FATE). This represents 0.0 percent ownership of the company. In their previous filing dated 2025-07-29 , Vanguard Group Inc had reported owning 8,766,764 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-03-26 2026-03-26 13G/A 8,766,764 0 -100.00 0.00 -100.00
2025-07-29 2025-07-29 13G/A 9,293,363 8,766,764 -5.67 7.64 -18.98
2024-02-13 2024-02-13 13G/A 9,936,042 9,293,363 -6.47 9.43 -6.82
2023-03-10 2023-03-10 13G/A 7,972,551 9,936,042 24.63 10.12 23.41
2023-02-09 2023-02-09 13G/A 7,675,787 7,972,551 3.87 8.20 1.99
2022-02-10 2022-02-10 13G/A 6,778,587 7,675,787 13.24 8.04 3.47
2021-02-10 2021-02-10 13G 6,778,587 7.77

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F FATE THERAPEUTICS COM 31189P102 8,971,347 172,856 1.96 8,819 -20.46 0.0001
2025-11-07 2025-09-30 13F FATE THERAPEUTICS COM 31189P102 8,798,491 31,727 0.36 11,086 12.92 0.0002
2025-08-11 2025-06-30 13F FATE THERAPEUTICS COM 31189P102 8,766,764 -1,543,689 -14.97 9,819 20.54 0.0002
2025-05-09 2025-03-31 13F FATE THERAPEUTICS COM 31189P102 10,310,453 -22,580 -0.22 8,145 -52.23 0.0001
2025-02-11 2024-12-31 13F FATE THERAPEUTICS COM 31189P102 10,333,033 -71,090 -0.68 17,050 -53.18 0.0003
2024-11-13 2024-09-30 13F FATE THERAPEUTICS COM 31189P102 10,404,123 -165,691 -1.57 36,414 5.04 0.0007
2024-08-13 2024-06-30 13F FATE THERAPEUTICS COM 31189P102 10,569,814 658,807 6.65 34,669 -52.34 0.0007
2024-05-10 2024-03-31 13F FATE THERAPEUTICS COM 31189P102 9,911,007 617,644 6.65 72,747 109.30 0.0014
2024-03-11 2023-12-31 13F/A-1 FATE THERAPEUTICS COM 31189P102 9,293,363 -1,614,988 -14.81 34,757 50.30 0.0008
2024-02-14 2023-12-31 13F FATE THERAPEUTICS COM 31189P102 9,293,363 -1,614,988 34,757 0.0007
2023-12-18 2023-09-30 13F/A-1 FATE THERAPEUTICS COM 31189P102 10,908,351 -815,023 -6.95 23,126 -58.56 0.0006
2023-11-14 2023-09-30 13F FATE THERAPEUTICS COM 31189P102 10,908,351 -815,023 23,126 0.0006
2023-08-14 2023-06-30 13F FATE THERAPEUTICS COM 31189P102 11,723,374 762,427 6.96 55,803 -10.68 0.0013
2023-07-14 2023-03-31 13F/A-1 FATE THERAPEUTICS COM 31189P102 10,960,947 2,988,396 37.48 62,477 -22.33 0.0016
2023-05-15 2023-03-31 13F FATE THERAPEUTICS COM 31189P102 10,960,947 2,988,396 62,477 0.0016
2023-02-10 2022-12-31 13F FATE THERAPEUTICS COM 31189P102 7,972,551 157,571 2.02 80,443 -54.07 0.0022
2022-11-14 2022-09-30 13F FATE THERAPEUTICS COM 31189P102 7,814,980 57,040 0.74 175,133 -8.90 0.0052
2022-08-12 2022-06-30 13F FATE THERAPEUTICS COM 31189P102 7,757,940 66,768 0.87 192,241 -35.53 0.0054
2022-05-13 2022-03-31 13F FATE THERAPEUTICS COM 31189P102 7,691,172 15,385 0.20 298,187 -33.60 0.0071
2022-02-14 2021-12-31 13F FATE THERAPEUTICS COM 31189P102 7,675,787 49,441 0.65 449,109 -0.64 0.0102
2021-11-12 2021-09-30 13F FATE THERAPEUTICS COM 31189P102 7,626,346 55,665 0.74 452,012 -31.21 0.0112
2021-08-13 2021-06-30 13F FATE THERAPEUTICS COM 31189P102 7,570,681 95,144 1.27 657,060 6.60 0.0164
2021-05-14 2021-03-31 13F FATE THERAPEUTICS COM 31189P102 7,475,537 696,950 10.28 616,358 0.00 0.0167
2021-02-12 2020-12-31 13F FATE THERAPEUTICS COM 31189P102 6,778,587 502,525 8.01 616,376 145.71 0.0179
2020-11-16 2020-09-30 13F FATE THERAPEUTICS COM 31189P102 6,276,062 1,177,511 23.10 250,855 43.40 0.0083
2020-08-14 2020-06-30 13F FATE THERAPEUTICS COM 31189P102 5,098,551 1,847,929 56.85 174,932 142.30 0.0062
2020-05-15 2020-03-31 13F FATE THERAPEUTICS COM 31189P102 3,250,622 125,853 4.03 72,197 18.06 0.0031
2020-02-14 2019-12-31 13F FATE THERAPEUTICS COM 31189P102 3,124,769 72,417 2.37 61,151 29.00 0.0021
2019-11-14 2019-09-30 13F FATE THERAPEUTICS COM 31189P102 3,052,352 324,362 11.89 47,403 -14.40 0.0018
2019-08-14 2019-06-30 13F FATE THERAPEUTICS COM 31189P102 2,727,990 6,146 0.23 55,378 15.80 0.0021
2019-05-15 2019-03-31 13F FATE THERAPEUTICS COM 31189P102 2,721,844 179,854 7.08 47,823 46.64 0.0019
2019-02-14 2018-12-31 13F FATE THERAPEUTICS COM 31189P102 2,541,990 93,711 3.83 32,613 -18.23 0.0015
2018-12-13 2018-09-30 13F/A-2 FATE THERAPEUTICS COM 31189P102 2,448,279 275,828 12.70 39,882 61.89 0.0016
2018-11-23 2018-09-30 13F/A-1 FATE THERAPEUTICS COM 31189P102 2,448,279 0 39,882 0.0016
2018-11-14 2018-09-30 13F FATE THERAPEUTICS COM 31189P102 2,448,279 275,828 39,882
2018-08-14 2018-06-30 13F FATE THERAPEUTICS COM 31189P102 2,172,451 354,730 19.52 24,636 38.86 0.0010
2018-05-15 2018-03-31 13F FATE THERAPEUTICS COM 31189P102 1,817,721 358,585 24.58 17,741 98.98 0.0008
2018-02-14 2017-12-31 13F FATE THERAPEUTICS COM 31189P102 1,459,136 176,143 13.73 8,916 75.51 0.0004
2017-11-14 2017-09-30 13F FATE THERAPEUTICS COM 31189P102 1,282,993 18,712 1.48 5,080 24.02 0.0002
2017-08-24 2017-06-30 13F/A-1 FATE THERAPEUTICS COM 31189P102 1,264,281 108,602 9.40 4,096 -22.10 0.0002
2017-08-11 2017-06-30 13F FATE THERAPEUTICS COM 31189P102 1,264,281 108,602 4,096
2017-05-12 2017-03-31 13F FATE THERAPEUTICS COM 31189P102 1,155,679 523,684 82.86 5,258 231.53 0.0003
2017-02-14 2016-12-31 13F FATE THERAPEUTICS COM 31189P102 631,995 -55,698 -8.10 1,586 -26.06 0.0001
2016-11-14 2016-09-30 13F FATE THERAPEUTICS COM 31189P102 687,693 30,120 4.58 2,145 91.86 0.0001
2016-08-10 2016-06-30 13F FATE THERAPEUTICS COM 31189P102 657,573 22,098 3.48 1,118 -2.27 0.0001
2016-05-13 2016-03-31 13F FATE THERAPEUTICS COM 31189P102 635,475 220,232 53.04 1,144 -18.23 0.0001
2016-02-08 2015-12-31 13F FATE THERAPEUTICS COM 31189P102 415,243 46,264 12.54 1,399 -28.88 0.0001
2015-11-12 2015-09-30 13F/A-1 FATE THERAPEUTICS COM 31189P102 368,979 31,741 9.41 1,967 -9.85 0.0001
2015-11-12 2015-09-30 13F/A-1 FATE THERAPEUTICS COM 31189P102 368,979 31,741 1,967 0.0001
2015-11-12 2015-09-30 13F FATE THERAPEUTICS COM 31189P102 4,691,807 146,520
2015-08-13 2015-06-30 13F FATE THERAPEUTICS COM 31189P102 337,238 156,600 86.69 2,182 147.11 0.0001
2015-05-15 2015-03-31 13F/A-1 FATE THERAPEUTICS COM 31189P102 180,638 8,700 5.06 883 2.08 0.0001
2015-05-14 2015-03-31 13F FATE THERAPEUTICS COM 31189P102 180,638 883
2015-02-12 2014-12-31 13F FATE THERAPEUTICS COM 31189P102 171,938 0 0.00 865 -2.15 0.0001
2014-11-12 2014-09-30 13F FATE THERAPEUTICS COM 31189P102 171,938 23,332 15.70 884 -5.76 0.0001
2014-08-11 2014-06-30 13F FATE THERAPEUTICS COM 31189P102 148,606 0 0.00 938 -35.18 0.0001
2014-05-13 2014-03-31 13F FATE THERAPEUTICS COM 31189P102 148,606 130,080 702.15 1,447 1,147.41 0.0001
2014-02-12 2013-12-31 13F FATE THERAPEUTICS COM 31189P102 18,526 18,526 116 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.